Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
26,384
Total Claims
$1.5M
Drug Cost
523
Beneficiaries
$2,839
Cost/Patient
Risk Score Breakdown 26/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
+44%
Opioid rate vs peers
3.2% vs 2.2% avg
+101%
Cost per patient vs peers
$2,839 vs $1,411 avg
+49%
Brand preference vs peers
15.9% vs 10.6% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
3.2%
Opioid Rate
851
Opioid Claims
$19K
Opioid Cost
8.6%
Long-Acting Rate
Brand vs Generic
Brand: 4,151 claims · $1.0M
Generic: 22,017 claims · $463K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 828 | $227K |
| Mirabegron | 197 | $48K |
| Dextromethorphan Hbr/Quinidine | 59 | $43K |
| Rivaroxaban | 153 | $41K |
| Cariprazine Hcl | 58 | $40K |
| Sitagliptin Phosphate | 117 | $32K |
| Insulin Aspart | 57 | $31K |
| Fluticasone/Umeclidin/Vilanter | 44 | $29K |
| Dulaglutide | 25 | $24K |
| Collagenase Clostridium Hist. | 33 | $24K |
| Lipase/Protease/Amylase | 40 | $23K |
| Insulin Glargine,hum.Rec.Anlog | 67 | $22K |
| Memantine Hcl | 402 | $22K |
| Empagliflozin | 70 | $21K |
| Potassium Chloride | 925 | $21K |
Prescribing Profile
Patient Profile
80
Avg Age
70%
Female
2.47
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About